Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)
Trial details
- Registry ID
- NCT05686408
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Tianeptine
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)NCT05686408 | Tonix Pharmaceuticals, Inc. | Phase 2 | Completed | 2023-09-29Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |